| Financial Year |
March 31 2023 |
| Monetary Funds |
3,389,492,060.42 |
| Held-for-trading Financial Assets |
25,000,000.00 |
| Notes Receivable |
211,270,405.02 |
| Accounts Receivable |
1,741,679,144.98 |
| Advances to Suppliers |
885,553,177.42 |
| Other Receivables |
185,889,231.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,434,707.42 |
| Dividend Receivable |
-- |
| Inventories |
2,065,059,381.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
111,193,797.08 |
| Total Current Assets |
10,937,487,023.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
847,859,499.63 |
| Investment Properties |
1,229,055,425.30 |
| Fixed Assetes |
1,380,705,485.01 |
| Under-construction Projects |
513,087,864.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
500,702,895.57 |
| R&D expenses |
-- |
| Goodwill |
154,276,232.45 |
| Long-Term Deferred and Prepaid Expenses |
14,323,258.47 |
| Deferred Income Tax Assets |
292,858,050.97 |
| Other Non-Current Assets |
1,151,689.12 |
| Sub-Total of Non-Current Assets |
5,167,904,958.75 |
| Total Assets |
16,105,391,981.78 |
| Short-Term Loans |
620,453,847.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,448,604,204.15 |
| Accounts Payable |
3,692,881,716.94 |
| Accounts Received In Advance |
3,842,742.47 |
| Employee Compensation Payable |
72,467,621.30 |
| Taxes Payable |
86,430,730.31 |
| Interest Payable |
-- |
| Dividend Payable |
768,160.00 |
| Other payables |
240,544,173.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,433,199.87 |
| Other Current Liabilities |
327,879,409.20 |
| Sub-Total of Current Liabilities |
9,017,213,225.82 |
| Long-term Loans |
1,004,255,147.09 |
| Bonds Payable |
1,017,702,133.32 |
| Long-Term Accounts Payable |
5,883,700.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
138,522,700.58 |
| Deferred Income Tax Liabilities |
16,399,731.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,913,998,510.82 |
| Total Liabilities |
11,931,211,736.64 |
| Paid-In Capital(Or Share Stock) |
739,202,416.00 |
| Capital Surplus |
743,227,273.91 |
| Surplus Reserve |
350,824,137.12 |
| LESS:Treasury Stock |
158,605,480.50 |
| Undistributed Profits |
1,850,202,677.52 |
| Minority Stockholder's Interest |
438,853,657.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,735,326,588.04 |
| Owner's Equity（Stockholder's Equity） |
4,174,180,245.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,105,391,981.78 |
